Paragon Biosciences was founded in 2010 as a company dedicated to global healthcare development and a biopharmaceutical investment firm. With the mission of accelerating medical breakthroughs for patients in need, Paragon Biosciences invests time and money into those companies focusing on diseases that are often times overlooked. Identifying and focusing on diseases where patient need is highest and available treatment is scarce is the main idea.
Paragon Biosciences is a parent company to several pharmaceutical companies as well as research and development companies all focusing on a variety of less common diseases. Paragon Biosciences supports researchers who dream big, committing all necessary infrastructure to help those researchers accomplish their goals. Paragon Biosciences believes fighting disease happens in four main areas: Advanced Science, Disease State, Education, and Community. Supporting these areas, it is only a matter of time before “the impossible yields to persistence, passion, and genius (Gazetteday).”
Leading this company is CEO and chairman Jeff Aronin. Gaining experience from being President and CEO of his self-founded Ovation Pharmaceuticals from 2000-2009, Jeff Aronin brings skills from both the business world and science. His skills include strategic and business development, finance, and brand marketing. From the science side, Jeff Aronin brings complex science, rare diseases, and drug development. Perhaps his greatest asset is the ability to bring teams of talented scientists and business executives together to research drug treatments and therapies.
Leading Paragon Biosciences since its inception, Jeff Aronin has received many honors for his entrepreneurship and patient-focused dedication in bringing new medicines to market. He believes wholeheartedly in the power of education supporting numerous education-based programs. He also believes in improving patient outcomes in all stages of disease and deeply supports those organizations that are dedicated to this focus. His beliefs are so strong that the employees of Paragon Biosciences share the same philanthropic vision.
Using Paragon Biosciences as his platform, Jeff Aronin is proving that size of a company is not what really matters. It is caring for the patients and trying to make a difference in the lives of those suffering from disease.